Jim Simons acquired 436 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $26.1 Million. That's 0.04% of their equity portfolio (506th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2013. Since then Jim Simons bought shares eighteen more times and sold shares on nineteen occasions. The investor's estimated purchase price is $36.8 Million, resulting in a loss of 29%.